UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Response rate of patients with baseline brain metastases from recently diagnosed non‐small cell lung cancer receiving radiotherapy according to EGFR, ALK and KRAS mutation status

Thoracic cancer, 2020-04, Vol.11 (4), p.1026-1037

2020

Volltextzugriff (PDF)

Association between nuclear expression of retinoic acid receptor alpha and beta and clinicopathological features and prognosis of advanced non-small cell lung cancer

International journal of clinical oncology, 2016-12, Vol.21 (6), p.1051-1061

2016

Volltextzugriff (PDF)

Cost-effectiveness analysis of EGFR mutation testing in patients with non-small cell lung cancer (NSCLC) with gefitinib or carboplatin–paclitaxel

The European journal of health economics, 2016-09, Vol.17 (7), p.855-863

2016

Volltextzugriff (PDF)

Characteristics of non-small cell lung cancer: differences by sex and hormonal status in a Mexican population

Salud pública de México, 2019-05, Vol.61 (3), p.265-275

2019

Volltextzugriff (PDF)

Lung cancer mortality and municipal marginalization in Mexico, 1998-2016

Salud pública de México, 2019-05, Vol.61 (3), p.249-256

2019

Volltextzugriff (PDF)

Efficacy and Safety of Pembrolizumab Plus Docetaxel vs Docetaxel Alone in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer: The PROLUNG Phase 2 Randomized Clinical Trial

JAMA oncology, 2020-06, Vol.6 (6), p.856

2020

Volltextzugriff (PDF)

Nutritional Status, Body Surface, and Low Lean Body Mass/Body Mass Index Are Related to Dose Reduction and Severe Gastrointestinal Toxicity Induced by Afatinib in Patients With Non‐Small Cell Lung Cancer

The oncologist (Dayton, Ohio), 2015-08, Vol.20 (8), p.967-974

2015

Volltextzugriff (PDF)

Effect of Metformin Plus Tyrosine Kinase Inhibitors Compared With Tyrosine Kinase Inhibitors Alone in Patients With Epidermal Growth Factor Receptor–Mutated Lung Adenocarcinoma: A Phase 2 Randomized Clinical Trial

JAMA oncology, 2019-11, Vol.5 (11), p.e192553

2019

Volltextzugriff (PDF)

Radical consolidative treatment provides a clinical benefit and long-term survival in patients with synchronous oligometastatic non-small cell lung cancer: A phase II study

Lung cancer (Amsterdam, Netherlands), 2019-04, Vol.130, p.67-75

2019

Volltextzugriff (PDF)

Association between CD47 expression, clinical characteristics and prognosis in patients with advanced non‐small cell lung cancer

Cancer medicine (Malden, MA), 2020-04, Vol.9 (7), p.2390-2402

2020

Volltextzugriff (PDF)

Randomized, open-label trial evaluating the preventive effect of tetracycline on afatinib induced-skin toxicities in non-small cell lung cancer patients

Lung cancer (Amsterdam, Netherlands), 2015-06, Vol.88 (3), p.282-288

2015

Volltextzugriff (PDF)

The Role of a Cachexia Grading System in Patients with Non-Small Cell Lung Cancer Treated with Immunotherapy: Implications for Survival

Nutrition and cancer, 2021, Vol.73 (5), p.794-801

2021

Volltextzugriff (PDF)

High liposomal doxorubicin tumour tissue distribution, as determined by radiopharmaceutical labelling with (99m)Tc-LD, is associated with the response and survival of patients with unresectable pleural mesothelioma treated with a combination of liposomal doxorubicin and cisplatin

Cancer chemotherapy and pharmacology, 2014-07, Vol.74 (1), p.211-215

2014

Volltextzugriff (PDF)

Different mutation profiles and clinical characteristics among Hispanic patients with non-small cell lung cancer could explain the “Hispanic paradox”

Lung cancer (Amsterdam, Netherlands), 2015-11, Vol.90 (2), p.161-166

2015

Volltextzugriff (PDF)

Diagnosis of EML4-ALK Translocation With FISH, Immunohistochemistry, and Real-time Polymerase Chain Reaction in Patients With Non-Small Cell Lung Cancer

American journal of clinical oncology, 2017-12, Vol.40 (6), p.631-638

2017

Volltextzugriff (PDF)

Radical aggressive treatment among non-small cell lung cancer patients with malignant pleural effusion without extra-thoracic disease

Journal of thoracic disease, 2019-02, Vol.11 (2), p.595-601

2019

Volltextzugriff (PDF)

FAACT-Anorexia Cachexia Scale: Cutoff Value for Anorexia Diagnosis in Advanced Non-Small Cell Lung Cancer Patients

Nutrition and cancer, 2019-04, Vol.71 (3), p.409-417

2019

Volltextzugriff (PDF)

Extended resections of large thymomas: importance of en bloc thymectomy

Journal of thoracic disease, 2018-06, Vol.10 (6), p.3473-3481

2018

Volltextzugriff (PDF)

Inequality in primary care interventions in maternal and child health care in Mexico

Revista panamericana de salud pública, 2014-04, Vol.35 (4), p.235-241

2014

Volltextzugriff (PDF)

Reproducibility of the EGFR immunohistochemistry scores for tumor samples from patients with advanced non-small cell lung cancer

Oncology letters, 2017-02, Vol.13 (2), p.912-920

2017

Volltextzugriff (PDF)

Reduction in Hepatocyte Growth Factor Serum Levels is Associated with Improved Prognosis in Advanced Lung Adenocarcinoma Patients Treated with Afatinib: a Phase II Trial

Targeted oncology, 2016-10, Vol.11 (5), p.619-629

2016

Volltextzugriff (PDF)

Characteristics of progression to tyrosine kinase inhibitors predict overall survival in patients with advanced non-small cell lung cancer harboring an EGFR mutation

Journal of thoracic disease, 2018-04, Vol.10 (4), p.2166-2178

2018

Volltextzugriff (PDF)

Abstract 5439: Study of polymorphisms in stra6 in Mexican population with non-small cell lung cancer

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.5439-5439

2018

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(49)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(24)
Science & Technology
(24)
Humans
(20)
Female
(18)
Male
(18)
Oncology
(18)
Middle Aged
(17)
Aged
(11)
Lung Cancer
(10)
Lung Neoplasms - Drug Therapy
(10)
Adult
(9)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(8)
Respiratory System
(8)
Prognosis
(7)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(6)
Chemotherapy
(6)
Lung Neoplasms - Mortality
(6)
Lung Neoplasms - Pathology
(6)
Mexico
(6)
Non-Small Cell Lung Cancer
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Response rate of patients with baseline brain metastases from recently diagnosed non‐small cell lung cancer receiving radiotherapy according to EGFR, ALK and KRAS mutation status

Association between nuclear expression of retinoic acid receptor alpha and beta and clinicopathological features and prognosis of advanced non-small cell lung cancer

Characteristics and long‐term outcomes of advanced pleural mesothelioma in Latin America (MeSO‐CLICaP)

Molecular Epidemiology of ALK Rearrangements in Advanced Lung Adenocarcinoma in Latin America

Cost-effectiveness analysis of EGFR mutation testing in patients with non-small cell lung cancer (NSCLC) with gefitinib or carboplatin–paclitaxel

Characteristics of non-small cell lung cancer: differences by sex and hormonal status in a Mexican population

Lung cancer mortality and municipal marginalization in Mexico, 1998-2016

Efficacy and Safety of Pembrolizumab Plus Docetaxel vs Docetaxel Alone in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer: The PROLUNG Phase 2 Randomized Clinical Trial

Nutritional Status, Body Surface, and Low Lean Body Mass/Body Mass Index Are Related to Dose Reduction and Severe Gastrointestinal Toxicity Induced by Afatinib in Patients With Non‐Small Cell Lung Cancer

Effect of Metformin Plus Tyrosine Kinase Inhibitors Compared With Tyrosine Kinase Inhibitors Alone in Patients With Epidermal Growth Factor Receptor–Mutated Lung Adenocarcinoma: A Phase 2 Randomized Clinical Trial

Radical consolidative treatment provides a clinical benefit and long-term survival in patients with synchronous oligometastatic non-small cell lung cancer: A phase II study

Association between CD47 expression, clinical characteristics and prognosis in patients with advanced non‐small cell lung cancer

Randomized, open-label trial evaluating the preventive effect of tetracycline on afatinib induced-skin toxicities in non-small cell lung cancer patients

The Role of a Cachexia Grading System in Patients with Non-Small Cell Lung Cancer Treated with Immunotherapy: Implications for Survival

High liposomal doxorubicin tumour tissue distribution, as determined by radiopharmaceutical labelling with (99m)Tc-LD, is associated with the response and survival of patients with unresectable pleural mesothelioma treated with a combination of liposomal doxorubicin and cisplatin

Different mutation profiles and clinical characteristics among Hispanic patients with non-small cell lung cancer could explain the “Hispanic paradox”

Diagnosis of EML4-ALK Translocation With FISH, Immunohistochemistry, and Real-time Polymerase Chain Reaction in Patients With Non-Small Cell Lung Cancer

Radical aggressive treatment among non-small cell lung cancer patients with malignant pleural effusion without extra-thoracic disease

FAACT-Anorexia Cachexia Scale: Cutoff Value for Anorexia Diagnosis in Advanced Non-Small Cell Lung Cancer Patients

Extended resections of large thymomas: importance of en bloc thymectomy

Inequality in primary care interventions in maternal and child health care in Mexico

Reproducibility of the EGFR immunohistochemistry scores for tumor samples from patients with advanced non-small cell lung cancer

Reduction in Hepatocyte Growth Factor Serum Levels is Associated with Improved Prognosis in Advanced Lung Adenocarcinoma Patients Treated with Afatinib: a Phase II Trial

Characteristics of progression to tyrosine kinase inhibitors predict overall survival in patients with advanced non-small cell lung cancer harboring an EGFR mutation

Abstract 5439: Study of polymorphisms in stra6 in Mexican population with non-small cell lung cancer

Suchergebnisse filtern